Chemomab Therapeutics Ltd. CMMB
1.23 USD +0.05 (+4.24%)
Nov 4, 2026, 3:58 PM EST
1.16 Day range 1.30
0.92 52-week range 2.99
- YTD
- -25.45%
- 1 year
- -53.93%
Ownership
Held by insiders 11.29%
Held by institutions 27.99%
Float held by institutions 31.55%
Institutions 17
Top institutional holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Orbimed Advisors LLC. | 9.23% | 1,741,273 | 2.87M | Sep 29, 2024 |
| Sphera Funds Management Ltd. | 6.44% | 1,214,575 | 2.00M | Sep 29, 2024 |
| Yelin Lapidot Holdings Management Ltd. | 4.29% | 809,717 | 1.34M | Sep 29, 2024 |
| Morgan Stanley | 2.13% | 402,272 | 663.75K | Sep 29, 2024 |
| Ikarian Capital, LLC | 1.13% | 213,392 | 352.10K | Sep 29, 2024 |
| Two Sigma Securities, LLC | 0.21% | 39,939 | 65.90K | Sep 29, 2024 |
Top mutual fund holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Blackstone Alternative Multi-Strategy Fund | 0.00% | 200 | 329 | Jun 29, 2024 |
Insiders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| MOR GEORGE ADI | Officer and Director | Sale | Jan 2, 2023 | 0 |
| ORBIMED ISRAEL GP LTD. | Beneficial Owner of more than 10% of a Class of Security | Sale | Jan 2, 2023 | 0 |